{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:27:47Z","timestamp":1786987667457,"version":"build-2736575974"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.diabet.2008.02.002","type":"journal-article","created":{"date-parts":[[2008,6,26]],"date-time":"2008-06-26T05:10:33Z","timestamp":1214457033000},"page":"386-388","source":"Crossref","is-referenced-by-count":21,"special_numbering":"P1","title":["Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus"],"prefix":"10.1016","volume":"34","author":[{"given":"C.","family":"Bayreuther","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hieronimus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lebrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2008.02.002_bib1","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJM199005313222202","article-title":"Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome","volume":"322","author":"Solimena","year":"1990","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.diabet.2008.02.002_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/347151a0","article-title":"Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase","volume":"347","author":"Baekkeskov","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.diabet.2008.02.002_bib3","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1210\/jc.81.4.1488","article-title":"Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with auto-immune polyendocrine syndrome type I","volume":"81","author":"Tuomi","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2008.02.002_bib4","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1212\/WNL.49.4.1026","article-title":"Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine auto-immunity","volume":"49","author":"Saiz","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.diabet.2008.02.002_bib5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.55.1.46","article-title":"Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy","volume":"55","author":"Peltola","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.diabet.2008.02.002_bib6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/01.WNL.0000151973.08426.7E","article-title":"Auto-immunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease","volume":"64","author":"Ramirez-Montealegre","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.diabet.2008.02.002_bib7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/WNL.52.4.857","article-title":"Cerebellar ataxia with glutamic acid decarboxylase autoantibodies","volume":"52","author":"Abele","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.diabet.2008.02.002_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archneur.58.2.225","article-title":"Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14\u00a0patients","volume":"58","author":"Honnorat","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.diabet.2008.02.002_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/1531-8249(199908)46:2<263::AID-ANA19>3.0.CO;2-0","article-title":"Selective suppression of cerebellar GABA-ergic transmission by an autoantibody to glutamic acid decarboxylase","volume":"46","author":"Ishida","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.diabet.2008.02.002_bib10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ana.21123","article-title":"Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases","volume":"61","author":"Manto","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.diabet.2008.02.002_bib11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/jnnp.2006.091116","article-title":"Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia","volume":"78","author":"Ishida","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.diabet.2008.02.002_bib12","doi-asserted-by":"crossref","first-page":"I19","DOI":"10.1007\/s00415-005-1105-4","article-title":"The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies","volume":"252","author":"Dalakas","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.diabet.2008.02.002_bib13","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S1474-4422(03)00534-9","article-title":"Excellent response to steroid treatment in anti-GAD cerebellar ataxia","volume":"2","author":"Lauria","year":"2003","journal-title":"Lancet Neurol"}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S126236360800092X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S126236360800092X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T10:57:41Z","timestamp":1545908261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S126236360800092X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S126236360800092X"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2008.02.002","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}